Asian Pacific Journal of Cancer Prevention

  • 제17권3호
  • /
  • Pages.1393-1397
  • /
  • 2016
  • /
  • 1513-7368(pISSN)
  • /
  • 2476-762X(eISSN)
아시아태평양암예방학회 (Asian Pacific Journal of Cancer Prevention)
권호 표지
DOI QR코드

DOI QR Code

Breast Cancer in Iranian Woman: Incidence by Age Group, Morphology and Trends

  • Rafiemanesh, Hosein (Department of Epidemiology and Biostatistics, School of Public Health, Shahid Beheshti University of Medical Sciences) ;
  • Salehiniya, Hamid (Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences) ;
  • Lotfi, Zahra (Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences)
  • 발행 : 2016.04.11
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Background: Breast cancer is the most common cancer and the first cause of cancer death in women worldwide, with infiltrating duct carcinoma as the most common morphology. This study aimed to investigate trend of breast cancer incidence by age groups and histological changes in Iranian women between 2003 and 2008. Materials and Methods: This is analytic study, carried out based on re-analysis of the Cancer Registry Center report of health deputy for women's breast cancer in Iran during a 6-year period (2003-2008). Statistical analysis for incidence time trends and morphology change percentage carried out joinpoint regression analysis using the software Joinpoint Regression Program. Results: A total of 36,340 cases were reported for Iranian women in the six years. Analytical trend showed an increasing incidence trend with significant annual percentage change (APC) of 15.2 (CI: 11.6 to 18.8). The lowest and highest significant increased trend were related to age groups of 40 to 44 years and above 85 years, respectively; with APCs of 13.0 and 25.1, respectively. Of total cases, 78.7% of cases were infiltrating duct carcinoma, decreasing from 82.0% in 2003 to 76.6% in 2008, which was significant with an APC equal to -1.76 (CI:-2.7 to -0.8). Conclusions: The incidence trend of breast cancer is rising in Iranian women. The highest incidence was observed in the age groups 45-65 and 80-85. In conclusion, to reduce breast cancer incidence and its burden, preventive and screening programs for breast cancer, especially in young women, are recommended in Iran.

키워드

참고문헌

  1. Almasi Z, Rafiemanesh H, Salehiniya H (2015). Epidemiology characteristics and trends of incidence and morphology of stomach cancer in Iran. Asian Pac J Cancer Prev, 16, 2757-61. https://doi.org/10.7314/APJCP.2015.16.7.2757
  2. Anand P, Kunnumakkara AB, Sundaram C, et al (2008). Cancer is a preventable disease that requires major lifestyle changes. Pharm Res, 25, 2097-116. https://doi.org/10.1007/s11095-008-9661-9
  3. Berg WA, Gutierrez L, NessAiver MS, et al (2004). Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer 1. Radiol, 233, 830-49. https://doi.org/10.1148/radiol.2333031484
  4. Chahine G, El Rassy E, Khazzaka A, et al (2015). Characteristics of incident female breast cancer in Lebanon, 1990-2013: Descriptive study of 612 cases from a hospital tumor registry. Cancer Epidemiol.
  5. Chin TM, Tan SH, Lim SE, et al (2005). Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians. Cancer Detect Prev, 29, 412-8. https://doi.org/10.1016/j.cdp.2005.06.009
  6. Daubisse-Marliac L, Delafosse P, Boitard JB, et al (2011). Breast cancer incidence and time trend in France from 1990 to 2007: a population-based study from two French cancer registries. Ann Oncol, 22, 329-34. https://doi.org/10.1093/annonc/mdq396
  7. Esteghamati A, Khalilzadeh O, Rashidi A, et al (2011). Physical activity in Iran: results of the third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007). J Physical Activity Health, 8, 27-35. https://doi.org/10.1123/jpah.8.1.27
  8. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International J Cancer, 127, 2893-917. https://doi.org/10.1002/ijc.25516
  9. Force UPST (2009). Screening for breast cancer: US Preventive Services Task Force recommendation statement. Ann Int Med, 151, 716. https://doi.org/10.7326/0003-4819-151-10-200911170-00008
  10. Jemal A, Bray F, Center MM, et al (2011). Global cancer statistics. CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
  11. Jemal A, Center MM, DeSantis C, et al (2010). Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiology Biomarkers Prev, 19, 1893-907. https://doi.org/10.1158/1055-9965.EPI-10-0437
  12. Jemal A, Ward E, Thun MJ (2007). Recent trends in breast cancer incidence rates by age and tumor characteristics among U.S. women. Breast Cancer Res, 9, R28. https://doi.org/10.1186/bcr1672
  13. Keyghobadi N, Rafiemanesh H, Mohammadian-Hafshejani A, et al (2015). Epidemiology and trend of cancers in the province of Kerman: southeast of Iran. Asian Pac J Cancer Prev, 16, 1409-13. https://doi.org/10.7314/APJCP.2015.16.4.1409
  14. Kolb TM, Lichy J, Newhouse JH (2002). Comparison of the performance of screening mammography, physical examination, and breast us and evaluation of factors that influence them: an analysis of 27,825 patient evaluations 1. Radiol, 225, 165-75. https://doi.org/10.1148/radiol.2251011667
  15. Li CI, Anderson BO, Daling JR, et al (2003). Trends in incidence rates of invasive lobular and ductal breast carcinoma. JAMA, 289, 1421-4. https://doi.org/10.1001/jama.289.11.1421
  16. Mehdi I, Monem EA, Al Bahrani BJ, et al (2014). Age at diagnosis of female breast cancer in Oman: Issues and implications. South Asian J Cancer, 3, 101-6. https://doi.org/10.4103/2278-330X.130442
  17. Mousavi SM, Gouya MM, Ramazani R, et al (2009). Cancer incidence and mortality in Iran. Ann Oncol, 20, 556-63.
  18. Mousavi SM, Montazeri A, Mohagheghi MA, et al (2007). Breast cancer in Iran: an epidemiological review. Breast J, 13, 383-91. https://doi.org/10.1111/j.1524-4741.2007.00446.x
  19. Naghibi S, Shojaizadeh D, Montazeri A, et al (2013). Epidemiology of breast cancer in mazandaran province, 2009-2010. J Mazandaran Univ Med Sci, 23, 113-20.
  20. Rafiemanesh H, Mehtarpoor M, Mohammadian-Hafshejani A, et al (2015a). Cancer epidemiology and trends in Sistan and Baluchestan province, Iran. Med J Islamic Republic Iran, 29, 752-9.
  21. Rafiemanesh H, Rajaei-Behbahani N, Khani Y, et al (2015b). Incidence trend and epidemiology of common cancers in the center of Iran. Global J Health Sci, 8, 146.
  22. Razi S, Rafiemanesh H, Ghoncheh M, et al (2015). Changing trends of types of skin cancer in Iran. Asian Pacific J Cancer Prev, 16, 4955-8. https://doi.org/10.7314/APJCP.2015.16.12.4955
  23. Santos SI (1999). Cancer epidemiology, principles and methods. Cancer epidemiology, principles and methods.
  24. Sasco AJ (2001). Epidemiology of breast cancer: an environmental disease? APMIS, 109, 321-32. https://doi.org/10.1034/j.1600-0463.2001.090501.x
  25. Saxena S, Rekhi B, Bansal A, et al (2005). Clinico-morphological patterns of breast cancer including family history in a New Delhi hospital, India--a cross-sectional study. World J Surg Oncol, 3, 67. https://doi.org/10.1186/1477-7819-3-67
  26. Tazhibi M, Dehkordi ZF, Babazadeh S (2014). Trends in breast cancer incidence rates by age and tumor characteristics of women in the city of Isfahan for the period 2001-2010: An application of joinpoint analysis. J Res Med Sci, 19, 319-25.
  27. Vakili M, Pirdehghan A, Adimi M, et al (2014). Epidemiology and trend of cancer in yazd, a central province of iran, 2005-2009. J Res Health Sci, 14, 210-3.
  28. WHO (2000). International classification of diseases for oncology: ICD-O.Geneva.
  29. Yang L, Yuan Y, Sun T, et al (2015). Population-based cancer incidence analysis in Beijing, 2008-2012. Chin J Cancer Res, 27, 13-21.

피인용 문헌

  1. The Shiraz Breast Cancer Registry (SBCR): study design and primary reports pp.1744-828X, 2018, https://doi.org/10.2217/pme-2018-0047
  2. Cytotoxicities of novel hydrazone compounds with pyrrolidine moiety: inhibition of mitochondrial respiration may be a possible mechanism of action for the cytotoxicity of new hydrazones vol.27, pp.9, 2018, https://doi.org/10.1007/s00044-018-2220-y
  3. Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC/AKT/MAPK signaling pathway vol.17, pp.1, 2019, https://doi.org/10.1186/s12964-018-0316-0